Baseline low modified health assessment questionnaire (MHAQ) predicts the state of remission estimated by clinical disease activity index and MHAQ at 1 year in tocilizumab-treated rheumatoid arthritis patients.
Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. shin-ya@hotmail.co.jp.
S
S
Kawashiri
Y
Y
Ueki
K
K
Migita
H
H
Nakamura
K
K
Aoyagi
A
A
Kawakami
D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006304:Health Status; D006801:Humans; D016015:Logistic Models; D008875:Middle Aged; D011237:Predictive Value of Tests; D012074:Remission Induction; D011795:Surveys and Questionnaires
D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; C502936:tocilizumab